Your browser doesn't support javascript.
loading
A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer.
Ware, Kathryn E; Thomas, Beatrice C; Olawuni, Pelumi D; Sheth, Maya U; Hawkey, Nathan; Yeshwanth, M; Miller, Brian C; Vietor, Katherine J; Jolly, Mohit Kumar; Kim, So Young; Armstrong, Andrew J; Somarelli, Jason A.
Afiliação
  • Ware KE; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.
  • Thomas BC; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, United States.
  • Olawuni PD; Dr. Kiran C Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, United States.
  • Sheth MU; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.
  • Hawkey N; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, United States.
  • Yeshwanth M; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.
  • Miller BC; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, United States.
  • Vietor KJ; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.
  • Jolly MK; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University Medical Center, Durham, NC, United States.
  • Kim SY; Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore, India.
  • Armstrong AJ; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Somarelli JA; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Front Mol Biosci ; 10: 1104505, 2023.
Article em En | MEDLINE | ID: mdl-37228586

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça